In the field of healthcare, investment decisions are made on the long term, according to Mihai Gabriel Miron, deputy general manager of Ropharma, and therefore market uncertainty is slowing down the respective plans.
He believes 2026 will be the most complicated one after the pandemic.
(English version by Catalina Apostoiu)